Genetic Marker Can Help Focus Prostate Cancer Therapies

[vc_row][vc_column][vc_column_text css=""]CLEVELAND, OH — Two studies conducted by the Cleveland Clinic revealed how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies, published in the October 12 issue of JAMA Oncology, suggest that men who inherit this...